Clinical Policy Bulletin: Benign Prostatic Hypertrophy (BPH) Treatments View Bulletin... View Article
PLEASANTON, Calif. – NeoTract, Inc., today announced that the Centers for Medicare and Medicaid Services (CMS) have issued two new codes that describe the UroLift® implant procedure for the treatment of enlarged prostate in the April 2014 Update of the Hospital Outpatient Prospective Payment System (OPPS).... View Article
PLEASANTON, CA, US, – NeoTract, Inc., today announced that the UK’s National Institute for Health and Care Excellence (NICE) has issued an Interventional Procedure Guidance (IPG) approving the UroLift prostatic urethral lift implant for use by UK doctors.... View Article
Urology Times Supplement: UroLift® System Treatment: Expert Panel Discussion View Supplement... View Article
PLEASANTON, Calif. – NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift® System,... View Article
PLEASANTON, CA, – NeoTract, Inc., today announced that it received De Novo approval from the U.S. Food and Drug Administration (FDA) to market the novel UroLift® System,... View Article
PLEASANTON, CA, – NeoTract, Inc., today announced the successful results of the 206-patient L.I.F.T. IDE Study, a multi-center, randomized, blinded study in patients with Benign Prostatic Hyperplasia (BPH).... View Article
US
AU
UK
DE
NDL
ES